Sana Biotechnology, Inc.
Company Stats
- Market Cap
- $872.6M
- as of Sep 30, 2026
- Shares Outstanding
- 299.4M
- Free Float
- 80.7%
Income Statement
- Operating Income
- -$250.3M
- Net Income
- -$244.2M
- EBITDA
- -$237.5M
- Non-cash Impairment
- $44.6M
Cash Flow
- Free Cash Flow
- -$144.8M
- FCF Yield
- -16.6%
- Owner FCF Yield
- -19.5%
Balance Sheet
- Cash & Equivalents
- $71.9M
Returns & Capital
- SBC, 3Y Avg
- $32.9M
Cash Flow by Year
| Year | Revenue | FCF | Margin |
|---|---|---|---|
| FY2025 | — | -$144.8M | — |
| FY2024 | — | -$256.6M | — |
| FY2023 | — | -$273.6M | — |
| FY2022 | — | -$310.9M | — |
| FY2021 | — | -$280.9M | — |
Annual filing data through FY ended December 31, 2025; shares and float as of November 4, 2026. Yields and enterprise value use the calculated market cap above, at its as-of date. Ratios are our calculations from reported figures.
Stronger demand supports expansion as pricing diverges